Ketamineone Capital Limited Stock Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and KetamineOne Capital are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days KetamineOne Capital Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, KetamineOne Capital is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.3 M | |
| Total Cashflows From Investing Activities | -1.1 M |
KetamineOne |
KetamineOne Capital Relative Risk vs. Return Landscape
If you would invest 0.00 in KetamineOne Capital Limited on September 29, 2025 and sell it today you would earn a total of 0.00 from holding KetamineOne Capital Limited or generate 0.0% return on investment over 90 days. KetamineOne Capital Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than KetamineOne, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
KetamineOne Capital Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for KetamineOne Capital's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as KetamineOne Capital Limited, and traders can use it to determine the average amount a KetamineOne Capital's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| KONEF |
Based on monthly moving average KetamineOne Capital is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of KetamineOne Capital by adding KetamineOne Capital to a well-diversified portfolio.
KetamineOne Capital Fundamentals Growth
KetamineOne Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of KetamineOne Capital, and KetamineOne Capital fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on KetamineOne Pink Sheet performance.
| Return On Equity | -6.56 | |||
| Return On Asset | -0.8 | |||
| Operating Margin | (3.89) % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 129.97 M | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 6.74 X | |||
| Revenue | 6.44 M | |||
| EBITDA | (24.3 M) | |||
| Cash And Equivalents | 315.2 K | |||
| Total Debt | 2.13 M | |||
| Debt To Equity | 2.18 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (3.64 M) | |||
| Earnings Per Share | (0.33) X | |||
About KetamineOne Capital Performance
By analyzing KetamineOne Capital's fundamental ratios, stakeholders can gain valuable insights into KetamineOne Capital's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if KetamineOne Capital has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if KetamineOne Capital has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada. Wellbeing Digital is traded on OTC Exchange in the United States.Things to note about KetamineOne Capital performance evaluation
Checking the ongoing alerts about KetamineOne Capital for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for KetamineOne Capital help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| KetamineOne Capital generated a negative expected return over the last 90 days | |
| KetamineOne Capital has some characteristics of a very speculative penny stock | |
| KetamineOne Capital Limited has accumulated 2.13 M in total debt with debt to equity ratio (D/E) of 2.18, implying the company greatly relies on financing operations through barrowing. KetamineOne Capital has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist KetamineOne Capital until it has trouble settling it off, either with new capital or with free cash flow. So, KetamineOne Capital's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like KetamineOne Capital sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for KetamineOne to invest in growth at high rates of return. When we think about KetamineOne Capital's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 6.44 M. Net Loss for the year was (25.21 M) with profit before overhead, payroll, taxes, and interest of 424.24 K. | |
| KetamineOne Capital Limited has accumulated about 315.2 K in cash with (3.64 M) of positive cash flow from operations. |
- Analyzing KetamineOne Capital's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether KetamineOne Capital's stock is overvalued or undervalued compared to its peers.
- Examining KetamineOne Capital's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating KetamineOne Capital's management team can have a significant impact on its success or failure. Reviewing the track record and experience of KetamineOne Capital's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of KetamineOne Capital's pink sheet. These opinions can provide insight into KetamineOne Capital's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for KetamineOne Pink Sheet analysis
When running KetamineOne Capital's price analysis, check to measure KetamineOne Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KetamineOne Capital is operating at the current time. Most of KetamineOne Capital's value examination focuses on studying past and present price action to predict the probability of KetamineOne Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KetamineOne Capital's price. Additionally, you may evaluate how the addition of KetamineOne Capital to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |